Abstract -Spin labels have now enjoyed a history of close to twenty-five years in demonstrating the applicability of paramagnetic nitroxides to biochemical problems of structure and function in enzymes, membranes, cells and animals. These have been employed traditionally as reporter groups; that is, the nitroxide spin label serves as a physical probe which reports aspects of its structure and environment at a localized molecular site. The work presented here describes the use of active-site directed fluorosulfonylphenyl nitroxide spin label inhibitors for the blood clotting enzyme, thrombin. The results describe a topographical mapping of the extended active site regions of coagulant human a-thrombin, noncoagulant human y-thrombin, and bovine a-thrombin. Subtle differences are revealed between all of these species and forms. Lastly, interactions between the regulatory protein thrombomodulin and spin labeled a -thrombin are described which confirms the propagation of subtle conformational changes to the catalytic site in the thrombin molecule upon complexation.
INTRODUCTION
Spin labels have now enjoyed a history of close to twenty-five years in demonstrating the applicability of paramagnetic nitroxides to biochemical problems of structure and function in enzymes, membranes, cells and animals. These have been employed traditionally as reporter groups; that is, the nitroxide spin label serves as a physical probe which reports aspects of its structure and environment at a localized molecular site. It has been quoted many times that this reporter group must "report the news" not "make the news". That is, it is important to insure that the sometimes bulky nitroxide spin label, does not perturb the macromolecular system under study.
To this end, several groups, particularly Berliner and colleagues (ref. l), have employed a comparative system of structural investigation to enzyme studies, whereby a spin label is placed at the same homologous site in a family of enzymes whose structures are highly similar.
In that way, any perturbations of the molecular structure (if they indeed occur) are identical in all systems tested.
Hence, the spin label becomes a valid tool for structural comparisons.
Perhaps one of the most enlightening studies in the use of nitroxide spin labels has been that with the proteolytic blood clotting enzyme, a-thrombin (ref. 2) . This is a member of the common serine protease family which, however, displays a much more restricted, unique specificity than the typical digestive enzymes such as achymotrypsin or trypsin. from either the human or bovine species has yet to be reported. Therefore, a study of the structure and environment of thrombin in solution is even more challengingresults from the x-ray crystal structure may eventually c o n f i r m results from solution studies (quite the opposite from past history!) Furthermore, to date the crystal structure of this enzyme
The approach of Berliner and colleagues has been to mimic an inhibitor or substrate analog known to covalently and specifically react with the serine residue 195 at the active site of a-thrombin and other serine proteases (ref. 1 ). An extensive series of fluorophenylsulfonyl spin labels were synthesized (shown in Fig. l) , all of which had the fluorosulfonylphenyl moiety in common and varied by the position and structure of the nitroxide moiety attached to the aromatic ring (ref. 3) . This also satisfied another important requirement for reporter group labeling studies: that is, one must acquire consistent reproducible results from more than one label. It is occasionally possible that structural results derived from the employment of a single label may be the reporter group "reporting the news," and not that of the protein structure itself. The spin labels, when organized in the order shown in Fig. 1 , may be classified into two general groups: a linear group of labels, mostly para-substituted on the phenyl ring; and a bent series of labels mostly those substituted in the meta position. Two additional labels, designated as mobile in the Fig. 1 , were difficult to classify on the enzyme as their freedom of rotation was so rapid that interactions with the protein structure could not be easily distinguished. These latter two fall in a case of labels which are simply not sensitive enough to the protein structure -not that the spin label method is of little use, but simply again showing the need for following a series of several labels (ref. labeled human a -and y-thrombins. Note that with this bent, m e t a -s u b s t i t u t e d derivative, the y-thrombin analog is significantly more immobilized than that of the a-form. Notably, this difference was found for e v e r y bent fluorosulfonyl phenyl spin label, all of which could be overlapped in structure within a small volume constraint. On the other hand, Fig. 4 shows comparative spectra for a parasubstituted, linear label, p -I where we note in spectra a and b that the lineshapes for a -and y-thrombin, respectively, are identical. That is, the structural environment sensed by the nitroxide in this case is identical in both enzyme forms. Thus, here we have an example of nitroxide spin labels detecting subtle conformational differences between human a-and y-thrombin where in one case we are detecting those regions which are different, while in the second case those regions that are identical. Upon binding specific reversible basic inhibitors, such as benzamidine or p-chlorobenzylamine, to any of the spin-labeled thrombin forms, we note (e.g., Figs. 3c,d and 4c) an increased immobilization of the nitroxide. That is, upon binding the ligand at the active site specificity pocket, the phenylsulfonyl moiety is effected similarly in a!l cases, presumably causing the phenylsulfonyl nitroxide spin label to adopt an alternate orientation in order to accommodate benzamidine binding simultaneously.
In most cases this results in a m o r e immobilized spectrum. Fig. 4d depicts thrombin labeled with the linear nitroxide spin label p-I, after exposure of either a-or y-thrombin to the hydrophobic, apolar ligand indole. Here we note an increased immobilization; that is, upon binding this ligand to some specific apolar site on the thrombin molecule, a change in the structure or environment of the nitroxide is detected with this particular spin label, resulting in increased immobilization.
This phenomenon occurred for all of the linear p a r a -substituted nitroxides while the effect was totally absent in all of the bent ( a -ythrombin difference) labels (ref. 4) . Here again is another example of the detection of subtle differences in the thrombin active site structure, here where the phenomenon exists in both a -and y-thrombin at some site d i f f e r e n t from that where the two structures differ significantly. By model building, a topographical map, shown in Fig. 5 , was constructed based on the rotational space available to this series of labels.
BOVINE THROMBINS
The primary structure of bovine a -thrombin is highly homologous to that of its human counterpart.
In fact, from a quick perusal of their minor amino acid differences, one would never suspect any major differences in their catalytic and/or specificity properties. Yet, while the noncoagulant y-form of human a-thrombin has essentially zero clotting activity, the corresponding bovine form (p -thrombin) retains 10% clotting activity: Km is unchanged and kcat is reduced 90% of that of the a-form (ref. 7) . thrombins with bent, m e t a -and linear para-substituted labels. It is important to note that in all cases the bovine analogs are more immobilized than that in the case of the human forms (Fig. 6 ). That is, it is clear that in the extended active site structure of bovine thrombin (i.e., the region at 10 -12A from serine 195) distinct differences exist in the structure and environment of the species (ref. 4) . When examining aspects such as indole binding (Fig. 7) , we note that the indole site also exists in bovine thrombin as well.
However, with the label m -V I I , these indoleeffects were noted in the case of bovine, but not human a-thrombin. On the other hand, the three other indole sensitive labels shown in Fig. 1 were common to both species in terms of eliciting an effect. That is, the bovine a-thrombin structure differs subtly in its apolar (indole binding) region from that of the human form, as detected by spin labels (particularly in the case of the nitroxide m -V I I ) .
Figs. 6 and 7 depict spin label spectra comparing human and bovine a- 
THROMBIN INTERACTIONS WITH OTHER COAGULATION RELATED MACROMOLECULES
Thrombin, besides being responsible for the catalysis of the hydrolysis of fibrinogen to fibrin (and eventually the blood clot), interacts with several other factors on hemostasis. In fact, it is the central enzyme in the control of hemostasis. Of particular interest is a protein called thrombomodulin, which has the properties of activating thrombin efficiency in a unique anticoagulant pathway; specifically, the protease, protein C, is involved in a negative feedback control process which inactivates enzymes in the blood clotting cascade which normally turns on thrombin (ref. 8). That is, there is a chain reaction for the onset of coagulation and a chain reaction for the shutdown of coagulation. Once thrombin levels are high enough, it is necessary not only to both inactivate thrombin but those enzymes which catalyze thrombin propagation. Protein C (PC) is one such anticoagulant enzyme, which is turned on by thrombin. In a unique regulatory system, the protein thrombomodulin (TM), activates thrombin activation of protein C from an inactivated noncatalytic form (PC) to the activated form (APC). The activation factor may be from 1,000 to 20,000, 'depending upon the species (refs. 8,9).
It was already known that thrombomodulin binds to some part of the thrombin surface which is not at the active site but somewhat removed, but the interaction causes conformational changes at the active site. Musci, Berliner, and Esmon examined the interactions between phenylsulfonyl spin-labeled human a-thrombin and a 50,000 MW active fragment (E-) of thrombomodulin (ref. 10). Fig. 8 shows an example of one of these studies. Fig. 8a is that for p-V labeled human a-thrombin in aqueous solution. Fig.  8c is the spectrum obtained for the e-thrombomodulin-thrombin complex.
Since the resultant molecular weight is now EI. 86,600, we would expect that macromolecular tumbling contributions should effect the overall nitroxide lineshape. Therefore, we examined isolated spin-labeled human a-thrombin in both 24% (w/v) and saturated sucrose (Figs. 8b,e ) and compared this with the analogous thrombin-thrombomodulin complex in both the presence (Fig. 8d) and absence of saturated sucrose (Figs. 8a,c) .
Comparison of both samples in saturated sucrose is important since the resultant lineshape reflects not only a reduced tumbling rate of the thrombin monomer (to near the time sensitivity limit of the conventional X-band ESR experiment), but also reflects microviscosity contributions the nitroxide moiety and the solution environment. As noted in the comparison between Figs. 8cand 8d for the thrombinthrombomodulin complex, there is additional line broadening in the presence of saturated sucrose, even though the overall macromolecular complex has slowed motion well below that of the ESR time sensitivity. By comparing the results of Figs. 8a and 8c, we may conclude that upon complexation with thrombomodulin, a conformational change is elicited in the active center around the region where the nitroxide moiety tumbles.
CONCLUSIONS
These results show the ability of spin labels to detect subtle conformational changes in a thrombin macromolecular complex, which will not be observable by X-ray crystallographic methods in the very near future.
